Status: Phase 3
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Sclerosis Phase 3 ClinicalTrials
CONTENTS